Quest Diagnostics Incorporated (DGX.MX)
| Previous close | 2,458.05 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 0 |
| Market cap | 273.07B |
| Beta (5Y monthly) | 0.89 |
| PE ratio (TTM) | 20.49 |
| EPS (TTM) | 119.95 |
| Earnings date | 23 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 08 Jul 2024 |
| 1y target est | N/A |
PR NewswireQuest Diagnostics Releases 2023 Corporate Responsibility Report
Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today released its 2023 Corporate Responsibility Report.
PR NewswireQuest Diagnostics to Acquire Select Lab Assets from Allina Health
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, and Allina Health, a leading, non-profit health care system, today announced a definitive agreement for Quest to acquire select laboratory assets from Allina Health, with the goal to improve access to and the affordability of innovative laboratory services across Minnesota and western Wisconsin.
- PR Newswire
Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024
Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report second quarter 2024 financial results on Tuesday, July 23, 2024, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.
